Cogent Biosciences (COGT.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec8

Cogent Biosciences Announces Positive Results for Bezuroclastinib in ADVSM Trial

12:33

Dec6

Cogent Biosciences Announces Positive Results for bezuclastinib in SUMMIT Trial

14:38

Dec2

Virtus Investment Advisers LLC Reduced Holdings in Cogent Biosciences in Q2

12:56

Dec1

Geode Capital Management LLC increased its stake in Cogent Biosciences stock

08:52

Nov18

Cogent Biosciences Raises $230 Million Through Convertible Debt Issuance

21:10

Nov15

Sam Slutsky Maintains Buy Rating for Cogent Biosciences

15:37

Schedules & Filings

Schedules

Filings

Nov3

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -80.93 M, EPS -0.588

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -73.53 M, EPS -0.6419

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -71.99 M, EPS -0.6348

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change